CIK 0001035354
- Non-accelerated filer
- Smaller reporting company
Eloxx Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ELOX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 841368850
- Phone
- +1 781-577-5300
- Business address
- P.O. BOX 274, ARLINGTON, MA, 02476
- Former names
- Sevion Therapeutics, Inc., SENESCO TECHNOLOGIES INC, NAVA LEISURE USA INC
- 4 Open-market buy Director bought 882,381 shares
- 4 Open-market buy Director bought 16,745 shares
- 4 Open-market sale Former President & CEO sold 49,500 shares at an average $0.38 ($18,770)
- 4 Returned to the company Former President & CEO returned 141,500 shares (to the company)
- 4 Returned to the company CFO and Treasurer returned 10,000 shares (to the company)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Returned to the company CFO and Treasurer returned 1,400 shares (to the company)
- 4 Returned to the company VP - Corporate Dev. returned 2,100 shares (to the company)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 6,250 shares at $0.90 ($2,000)
- 4 Open-market buy Director bought 275,000 shares at $0.90 ($88,000)
- 4 Open-market buy Director bought 6,250 shares at $0.90 ($2,000)
Page 21 of 29 · 574 filings